Export
From: Whisnant, Leeanne   Sent: Tue, 10 Sep 2019 15:34:48 GMT
To: Walker, Billie
Subject: FW: ALERT: Your Influenza Vaccine Shipment Will Be Arriving Soon

When are we starting flu shots ?

 

Leeanne Whisnant,MS,BSN

Alexander County Health Director

338 1st Ave SW Taylorsville,NC 28681

828-632-9704 Ext. 405

www.AlexanderHealth.org

 

From: Miller, Toni <tmiller@alexandercountync.gov>
Sent: Tuesday, September 10, 2019 10:56 AM
To: Vick, Emily <evick@alexandercountync.gov>
Cc: Walker, Billie <bwalker@alexandercountync.gov>; Pishner, Laurie <lpishner@alexandercountync.gov>; Whisnant, Leeanne <lwhisnant@alexandercountync.gov>
Subject: FW: ALERT: Your Influenza Vaccine Shipment Will Be Arriving Soon

 

 

 

From: sanofipasteurteam@sanofi.com [mailto:sanofipasteurteam@sanofi.com]
Sent: Tuesday, September 10, 2019 10:22 AM
To: Miller, Toni
Subject: ALERT: Your Influenza Vaccine Shipment Will Be Arriving Soon

 

 

 

 

 

 

Thank you for choosing Sanofi Pasteur as your partner for the 2019-2020 influenza season. You are scheduled to receive a shipment of vaccine the week of 10/4/2019. If supply is available sooner, your vaccine may ship up to 2 weeks earlier.

 

Please review your shipping information below.

No action is required unless the information is incorrect.

 

Ship-to address:

ALEXANDER COUNTY HEALTH DEPT
70075086
338 1ST AVE SW STE 1
TAYLORSVILLE, NC 28681
Telephone: 828-632-9704
Email: tmiller@alexandercountync.gov

 

 

Shipment details:

Order number: 0013138348
PO number: 2000096-00

 

Product Code

Product

Units
in this shipment

Doses
in this shipment

TOTAL UNITS RESERVED

TOTAL DOSES RESERVED

631-15

Fluzone Quadrivalent vaccine
5 mL multi-dose vial

21

210

60

600

 

 

 

If any of the information above is incorrect,
please log on to VaccineShoppe.com
® or call
1-8‌00-‌VA‌CCIN‌E (1-8‌00-‌822‌-24‌6‌3) within 24 hours.

 

 

 

 

Shipments should arrive between Monday and Friday during your normal business hours, as indicated on your Vaccin‌eShopp‌e‌.‌com account. If you have any changes to your normal business hours, please contact us at 1‌-8‌00‌-VAC‌CINE (‌1-‌8‌00‌-8‌22-‌2‌463).

 

You can also receive text message alerts to get real-time shipping updates. To add text message alerts to an existing influenza reservation, please log on to Va‌ccineS‌hopp‌e‌.‌c‌om or call 1-‌800‌-VAC‌CINE (‌1-80‌0‌-82‌2-‌2463‌).

 

All reservations are subject to Sanofi Pasteur's Terms and Conditions of Sale, including credit review, in effect at the time of reservation confirmation. Copies are available upon request or by logging on to V‌accine‌Shopp‌e.‌co‌m‌.

 

Remind patients to come in for their influenza vaccine.
Use WellConnect®, an easy-to-use, web-based broadcast messaging system, to let your patients know that your practice has influenza vaccine available. For more information, please contact your representative.

 

Indication for Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose Vaccines

 

Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose vaccines are indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B virus(es) contained in each vaccine. Flublok Quadrivalent vaccine is approved for use in persons 18 years of age and older. Fluzone Quadrivalent vaccine is approved for use in persons 6 months of age and older. Fluzone High-Dose vaccine is approved for use in persons 65 years of age and older.

 

Important Safety Information For Flublok Quadrivalent, Fluzone Quadrivalent, And Fluzone High-Dose Vaccines

 

Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose vaccines should not be administered to anyone who has had a severe allergic reaction (eg, anaphylaxis) to any component of the vaccine (including egg protein for Fluzone Quadrivalent and Fluzone High-Dose vaccines) or after a previous dose of the respective vaccine. In addition, Fluzone Quadrivalent and Fluzone High-Dose vaccines should not be administered to anyone who has had a severe allergic reaction after a previous dose of any influenza vaccine.

 

If Guillain-Barré syndrome has occurred within 6 weeks following previous influenza vaccination, the decision to give Flublok Quadrivalent, Fluzone Quadrivalent, or Fluzone High-Dose vaccine should be based on careful consideration of the potential benefits and risks.

 

In adults, the most common local and systemic adverse reactions to Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose vaccines include pain at the injection site; headache and myalgia. In children, the most common reactions to Fluzone Quadrivalent vaccine include pain, erythema, and swelling at the injection site; myalgia, malaise, and headache (irritability, abnormal crying, drowsiness, appetite loss, vomiting, and fever in young children). Other adverse reactions to these vaccines may occur. Vaccination with Flublok Quadrivalent, Fluzone Quadrivalent, or Fluzone High-Dose vaccine may not protect all individuals.

 

Before administration, please see the full Prescribing Information for Flublok Quadrivalent, Fluzone Quadrivalent, or Fluzone High-Dose vaccine.

 

 

SANOFI PASTEUR. Discovery Drive. Swiftwater, Pennsylvania 18370. www.sanofi.us
SAUS.SFLU.19.03.1892                           ® 2019 Sanofi Pasteur Inc.                    7/19

sanofi pasteur

 

 

Please do not reply to this message. Replies to this message are routed to an unmonitored mailbox.
If you have questions, please visit Customer Support at VaccineShoppe.com or call 1-800-VACCINE (1-800-822-2463). Click to view our Privacy Policy.